#RDRP
ERDRP-0519, a non-nucleoside inhibitor of Measles virus polymerase, also inhibits Nipah virus RdRp but with reduced potency due to less interaction. #Science PMID:42061399, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
No description available
www.cell.com
November 12, 2026 at 10:00 PM
ERDRP-0519, a non-nucleoside inhibitor targeting Measles virus (MeV) polymerase, also cross-inhibits Nipah virus (NiV) with lower potency, binding to a shared pocket in RdRp. Enhanced interactions with… PMID:42061399, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9 #RNA 🧪
https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
No description available
www.cell.com
November 8, 2026 at 6:00 PM
Open Access UCL Research: Fragment-based drug discovery targeting SARS-CoV-2 nsp10 and ATP catalytic cycle study on human microtubule depolymerase kinesin MCAK, with biophysical characterisations of ligand interactions with Dengue virus RdRp and Keap1 proteins discovery.ucl.ac.uk/id/eprint/10...
Fragment-based drug discovery targeting SARS-CoV-2 nsp10 and ATP catalytic cycle study on human microtubule depolymerase kinesin MCAK, with biophysical characterisations of ligand interactions...
UCL Discovery is UCL's open access repository, showcasing and providing access to UCL research outputs from all UCL disciplines.
discovery.ucl.ac.uk
November 9, 2026 at 1:57 PM
ERDRP-0519, a non-nucleoside inhibitor targeting MeV, also inhibits NiV polymerase, albeit less effectively. It binds to a shared site in RdRp palm domains, showing stronger interactions with Morbilliviruses… PMID:42061399, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
No description available
www.cell.com
November 3, 2026 at 6:00 AM
ERDRP-0519, a non-nucleoside inhibitor, shows strong activity against MeV and cross-inhibits NiV with lower potency, binding to a shared pocket in RdRp. PMID:42061399, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
No description available
www.cell.com
November 1, 2026 at 5:00 AM
ERDRP-0519, a polymerase inhibitor for Measles virus (MeV), also cross-inhibits Nipah virus (NiV) with reduced potency, binding to a shared pocket in RdRp. Remarkably, it forms more extensive interactions with… PMID:42061399, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
No description available
www.cell.com
October 28, 2026 at 4:00 PM
💊Target Mechanism: It targets the viral RNA-dependent RNA polymerase (RdRp) rather than the rapidly mutating spike protein, which allows it to resist viral evolution and maintain efficacy across newer strains,
October 28, 2026 at 7:29 AM
ERDRP-0519 is a novel non-nucleoside inhibitor targeting Measles virus (MeV) polymerase, also showing cross-inhibition of Nipah virus (NiV) with reduced efficacy. It binds to a shared pocket in the RdRp palm… PMID:42061399, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
No description available
www.cell.com
October 24, 2026 at 3:00 PM
ERDRP-0519, a non-nucleoside polymerase inhibitor, shows strong inhibition of MeV and weaker activity against NiV, binding to a shared pocket in RdRp. Enhanced interactions with Morbillivirus may drive… PMID:42061399, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9 #RNA 🧪
https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
No description available
www.cell.com
October 21, 2026 at 4:00 AM
ERDRP-0519 effectively inhibits Measles virus (MeV) polymerase and also targets Nipah virus (NiV) polymerase, albeit with reduced potency, by binding to a shared pocket in RdRp. Extensive interactions with… PMID:42061399, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
No description available
www.cell.com
October 19, 2026 at 5:00 AM
Studying the Deep Evolution of Viruses in the Era of Artificial Intelligence Structure Prediction
doi.org/10.1146/annu...
October 16, 2026 at 11:59 AM
🦠 How does SARS-CoV-2 develop antiviral resistance?

This highly cited review in Viruses covers RdRp & Mpro mutations, vaccine escape, and even wastewater-driven resistance.

Open access 👇
www.mdpi.com/1999-4915/17...

#COVID19 #AntiviralResistance
October 16, 2026 at 7:29 AM
ERDRP-0519 is a non-nucleoside inhibitor targeting Measles virus polymerase but also inhibits Nipah virus polymerase with reduced potency, highlighting key interactions in RdRp binding. PMID:42061399, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9 #Medsky #Pharmsky #RNA 🧪
https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
No description available
www.cell.com
October 13, 2026 at 3:00 AM
ERDRP-0519, a non-nucleoside inhibitor targeting MeV polymerase, also inhibits NiV RdRp but with less potency. It binds to a shared pocket in both, showing extensive interactions with Morbillivirus polymerases. PMID:42061399, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
No description available
www.cell.com
October 10, 2026 at 3:00 AM
We tested three major ToBRFV proteins: the replication protein (RdRp), coat protein (CP) and movement protein (MP).

Only MP triggered HREZ-dependent cell death in Nicotiana benthamiana.

This provides direct evidence that ToBRFV MP activates HREZ.

(3/9)
October 8, 2026 at 3:29 PM
Alternatively, Elfiky (2020) examined various antivirals targeting the RNA-dependent RNA polymerase (RdRP) of various viruses. Among HIV antivirals, this work identified Galidesivir, Remdesivir, and Tenofovir as being active against this part of the SARS-CoV-2 virus.

11/
October 8, 2026 at 2:33 PM
Elifky (2020) - SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective pmc.ncbi.nlm.nih.gov/articles/PMC...

Sales (2025) - Efficacy of tenofovir on clinical outcomes of COVID-19 patients: a systematic review pmc.ncbi.nlm.nih.gov/articles/PMC...

17/
SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective
New treatment against SARS-CoV-2 now is a must. Nowadays, the world encounters a huge health crisis by the COVID-19 viral infection. Nucleotide inhibitors gave a lot of promising results in terms of i...
pmc.ncbi.nlm.nih.gov
October 8, 2026 at 2:36 PM
#NowPlaying: The Dahmers - "Nightmare of '78" www.youtube.com/watch?v=RdRP...
THE DAHMERS - NIGHTMARE OF '78 (Official Video)
YouTube video by The Dahmers
www.youtube.com
October 7, 2026 at 9:35 PM
#RNAVirusJournalClub! The co-founder of RdRp Summit
@urineri.bsky.social will introduce the #RolyPoly - a python library for various common virus analysis tasks.

🍁Thur, October 8th, 8am London time. 🍁

Hosted by the RdRp Summit 2027 lead: @marcoforgia.bsky.social 🍁
All welcome! 😊
#RdRpSummit
October 5, 2026 at 8:11 PM
ERDRP-0519 inhibits Morbillivirus (e.g., Measles) RdRp effectively but shows reduced potency against Henipavirus (Nipah). It binds uniquely to shared RdRp pockets, highlighting potential targets for optimizing… PMID:42061399, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
https://www.cell.com/cell/fulltext/S0092-8674(26)00400-9
No description available
www.cell.com
October 2, 2026 at 6:00 AM
Identification of Novel Inhibitors of JEV RdRp as Potent Antiviral Drugs: Targeting NS5-NS3 Protein Interaction https://www.biorxiv.org/content/10.64898/2026.09.23.753689v1
September 29, 2026 at 6:00 AM
Identification of Novel Inhibitors of JEV RdRp as Potent Antiviral Drugs: Targeting NS5-NS3 Protein Interaction https://www.biorxiv.org/content/10.64898/2026.09.23.753689v1
September 29, 2026 at 6:00 AM
A nice little busking script starting to come together.
#redm #redmroleplay #redmrp #RDRP #RDR2 #twitch #twitchstreamer #streamer
September 24, 2026 at 7:59 PM
September 24, 2026 at 11:27 AM